News

U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures

U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures U.S. Patent for…

2 years ago

Monte Rosa Therapeutics to Present at 5th Annual Targeted Protein Degradation Summit and 34th EORTC-NCI-AACR Symposium

– New and Updated Preclinical Data Highlight Potential of GSPT1-directed Molecular Glue Degrader (MGD) MRT-2359 in the Treatment of MYC-driven…

2 years ago

Nanox to Host and Livestream ‘ARC Day’ event: Company’s Demonstration of Nanox’s Ecosystem

ARC Day will publicly demonstrate Nanox’s end-to-end 3D medical imaging solution in-person and onlineNEVE ILAN, Israel, Oct. 20, 2022 (GLOBE NEWSWIRE)…

2 years ago

Nyxoah to Participate in the Jefferies London Healthcare Conference

Nyxoah to Participate in the Jefferies London Healthcare Conference Mont-Saint-Guibert, Belgium – October 20, 2022, 10:30pm CET / 4:30pm ET…

2 years ago

Travere Therapeutics to Report Third Quarter 2022 Financial Results

SAN DIEGO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter…

2 years ago

Hepion Pharmaceuticals Announces Publication of Food Effect Study with Rencofilstat

EDISON, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial…

2 years ago

Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors

Lars Ekman and Patrick O’Sullivan to Retire from Amarin Board at year-end New Independent Directors Bring Significant International Experience in…

2 years ago

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September…

2 years ago

P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook

Strong First-Half 2022 revenue growth of 84% compared to the First-Half 2021At-risk Medicare Advantage members exceeded 100,000 at the end…

2 years ago

Codexis to Report Third Quarter 2022 Financial Results on November 3

REDWOOD CITY, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the…

2 years ago